Published in Neurocase on February 01, 2005
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94
Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology (2005) 5.51
Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain (1996) 4.61
Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet (2001) 4.28
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol (2000) 3.99
The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging (1997) 3.94
Prion dementia without characteristic pathology. Lancet (1990) 3.66
Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology (2005) 3.58
Extrapyramidal signs in dementia of Alzheimer type. Lancet (1989) 3.52
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology (2009) 3.49
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol (2001) 3.43
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
Solar disinfection of drinking water and diarrhoea in Maasai children: a controlled field trial. Lancet (1997) 3.20
Does levodopa accelerate the pathologic process in Parkinson disease brain? Neurology (2011) 3.10
Correlation between rates of brain atrophy and cognitive decline in AD. Neurology (1999) 3.07
Conservation. Challenges to the future conservation of the Antarctic. Science (2012) 3.01
The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry (2003) 2.97
Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet (1996) 2.89
Cortical lesions in multiple sclerosis. Brain (1999) 2.83
Impaired social response reversal. A case of 'acquired sociopathy'. Brain (2000) 2.81
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology (2005) 2.77
Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed (1997) 2.56
An adenosine triphosphate-dependent stabilization of proteolytic activity in heterolysosomes. Evidence for a proton pump. Biochem J (1972) 2.51
PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49
Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology (2000) 2.47
Oral methotrexate: the hazard of different tablet strengths. Rheumatology (Oxford) (1999) 2.47
The evolution of Titan's mid-latitude clouds. Science (2005) 2.46
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. J Comput Assist Tomogr (1998) 2.20
Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol (2004) 2.19
A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A (2000) 2.11
Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology (2001) 2.09
Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. AJNR Am J Neuroradiol (1998) 2.04
The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol (2012) 2.03
Predisposing locus for Alzheimer's disease on chromosome 21. Lancet (1989) 1.99
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology (2009) 1.95
Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol (2001) 1.94
A clinico-pathological study of subtypes in Parkinson's disease. Brain (2009) 1.91
Burkholderia pseudomallei virulence: definition, stability and association with clonality. Microbes Infect (2001) 1.90
Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation. Neuropathol Appl Neurobiol (2006) 1.88
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology (2009) 1.88
The heritability and genetics of frontotemporal lobar degeneration. Neurology (2009) 1.86
The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study. J Neurol Neurosurg Psychiatry (2008) 1.84
Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. J Clin Oncol (1995) 1.74
Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology (2005) 1.73
The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology (2006) 1.71
Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology (2003) 1.71
Automated hippocampal segmentation by regional fluid registration of serial MRI: validation and application in Alzheimer's disease. Neuroimage (2001) 1.71
Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet (1999) 1.68
Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol (2001) 1.68
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain (1992) 1.66
Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain (1998) 1.63
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
Corpora amylacea in hippocampal sclerosis. J Neurol Neurosurg Psychiatry (1997) 1.60
Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology (2002) 1.60
Inhibition of Lactation by Synthetic Oestrogens. Br Med J (1942) 1.60
Differential survival in horses requiring end-to-end jejunojejunal anastomosis compared to those requiring side-to-side jejunocaecal anastomosis. Equine Vet J (2007) 1.56
Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol (1998) 1.52
Cloning and sequence analysis of desmosomal glycoproteins 2 and 3 (desmocollins): cadherin-like desmosomal adhesion molecules with heterogeneous cytoplasmic domains. J Cell Biol (1991) 1.49
Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol (2007) 1.48
Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet (1970) 1.47
Health and cancer prevention: knowledge and beliefs of children and young people. BMJ (1995) 1.46
Solar disinfection of water reduces diarrhoeal disease: an update. Arch Dis Child (1999) 1.45
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol (2003) 1.44
Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett (1995) 1.44
A multidisciplinary team approach to skull base chordomas. J Neurosurg (2001) 1.44
Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain (2000) 1.43
Congenital aplasia and dysplasia of the tibia with intact fibula. Classification and management. J Bone Joint Surg Br (1978) 1.42
Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J Neurol Neurosurg Psychiatry (1989) 1.41
[Translation of titles into English in Medicina Clínica: quality and influence of the Spanish language]. Med Clin (Barc) (1996) 1.40
A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. Neuroimage (2008) 1.40